PAEA EOC & Summative Practice | Q&A Latest 2024/2025 | 100%
PAEA EOC & Summative Practice | Q&A Latest 2024/2025 | 100% what exactly causes the occlusive vascular disease of thromboangiitis obliterans? - Answer -aka Buerger's disease inflammatory thrombi affecting the medium and small vessels (nonatherosclerosis) polymorphonuclear leukocytes, microabscesses, and multinucleated giant cells may be presen Treatment options for thromboangiitis obliterans? - Answer -smoking cessation most important! cilostazol (PDE 3 inhibitor) has vasodilator properties (alleviated symptoms) if raynauds also present, CCB (nifedipine) what heart failure treatment provides a benefit of reduction in morbidity and mortality? - Answer -ACE inhibitors beta blockers can also reduce M&M
Written for
- Institution
- PAEA
- Course
- PAEA
Document information
- Uploaded on
- February 7, 2025
- Number of pages
- 40
- Written in
- 2024/2025
- Type
- Exam (elaborations)
- Contains
- Questions & answers
Subjects
-
paea eoc summative practice 2024
-
paea eoc summative practice 2025
-
what exactly causes the occlusive vascular disease
Also available in package deal